Skip to main content

Table 4 Mean platelet count in diffrent weeks of treatment

From: Impact of different anti-HCV regimens on platelet count during treatment in Egyptian patients

Platelet count (×103 cell/mm3) All patients
mean ± SD,
mean PLT, % drop to baseline
Group 1
Triple
(n 56), mean PLT, % drop to baseline
Group 2
SOF/RBV
(n 55) mean PLT, % drop to baseline
Group 3
SIM/SOF
(n 57)
mean PLT, % drop to baseline
p value (among three groups)
Baseline PLT 108.85 ± 39.74 136.89 ± 31.70 77.18 ± 18.01 111.84 ± 40.35 < 0.001
Week 1 89.72 ± 27.93
18%
86.89 ± 23.62
37%
75.89 ± 14.09
3%
105.84 ± 33.56
6%
< 0.001
Week 2 90.87 ± 33.90
17%
99.50 ± 36.89
28%
72.58 ± 12.30
7%
100.04 ± 38.18
10%
< 0.001
Week 3 87.65 ± 25.17
20%
96.05 ± 28.4
30%
76.07 ± 13.23
2%
90.58 ± 26.68
19%
< 0.001
Week 4 88.46 ± 32.08
19%
101.71 ± 44.1
26%
77.55 ± 14.26
0%
85.98 ± 25.69
24%
< 0.001
Week 8 94.98 ± 37.93
13%
97.05 ± 39.27
29%
87.73 ± 30.95 99.93 ± 42.08
11%
0.312
Week 12 99.46 ± 41.84
9%
102.86 ± 46.37
25%
90.16 ± 30.62 105.31 ± 45.67
6%
0.17